You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

184 Results
Document
Guidelines and Advice
Status: Archived
ID: 6-22
Jan 2007
This page is for people newly diagnosed with ALL.
Guidelines and Advice
Status: Archived
ID: 1-9
Jun 2010
Guidelines and Advice
Status: Education and Information
Dec 2012
Guidelines and Advice
Status: Current
ID: GL END 7-24
Nov 2024
Guidelines and Advice
Status: Current
ID: GL END 5-7
Version: 3
Nov 2021
Guidelines and Advice
Status: Archived
ID: 12-8
Version: 2
Jun 2013
Guidelines and Advice
Status: Current
ID: GL-END-C50-35
Aug 2023
Drug
Other Name(s): Somatuline® Autogel®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2024
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant, Adjuvant
Funding:
New Drug Funding Program
  • Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
DOXOrubicin,
cyclophosphamide,
PACLitaxel,
trastuzumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph, Patient Info Sheet (AC-PACL(DD)), Patient Info Sheet (AC-PACL(DD)+TRAS)
Jan 2024

Pages